EMD-48667

Single-particle
3.73 Å
EMD-48667 Deposition: 15/01/2025
Map released: 22/07/2026
Last modified: 22/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-48667

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9mvf summary report (pdf.gz) Map-9mvf FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Dengue virus serotype-4 (DENV4) complex with DCSIGN CRD at 4C

EMD-48667

Single-particle
3.73 Å
EMD-48667 Deposition: 15/01/2025
Map released: 22/07/2026
Last modified: 22/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Dengue virus 4 Dominica/814669/1981, Homo sapiens
Sample: Dengue virus 4 Dominica/814669/1981
Fitted models: 9mvf

Deposition Authors: Are VN, Fokine A, Klose T, Kuhn RJ, Center for Structural Biology of Infectious Diseases (CSBID)

Cryo-EM structures and biochemical assays demonstrate dengue viruses utilize heparin and glycan binding receptor DC-SIGN for infection

Are VN, Kuhn RJ
To Be Published